Skip to main content
OpenTrials
Completed

NCT Number: NCT07191652

The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index

Delirium is a postoperative complication that hinders a child's recovery and presents challenges in assessment and management. Ear nose throat (ENT) procedures have been suggested as a risk factor for delirium[1]. While numerous studies have explored the effect of sevoflurane on increasing delirium[2], data regarding opioids remain unclear. This study aims to retrospectively evaluate the incidence of emergence agitation and delirium in pediatric patients following otolaryngology surgery under opioid and opioid-free anesthesia approaches that are routinely used in anesthetic practice for these procedures.

Investigators hypothesis posits that a reduced incidence of burst suppression and opioid-free anesthesia may prevent delirium. The primary aim of this study is to retrospectively evaluate the incidence of emergence agitation and delirium following routine opioid-based and opioid-free anesthesia approaches in pediatric patients undergoing ENT surgeries. The secondary aim is to retrospectively assess late postoperative pain and patient satisfaction.

Completed

Looking for future studies?

Notify Me

Key information

About this study

It has been suggested that ear, nose, and throat (ENT) surgeries may be a risk factor for the development of delirium.

This study will be conducted retrospectively following approval from the Ethics Committee, by reviewing the medical records of pediatric patients who underwent ENT surgery at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Otorhinolaryngology between January 2024 and June 2025. In our clinic, both opioid-restricted and non-restricted general anesthesia techniques are routinely applied in pediatric ENT surgeries, and the data of these patients will be analyzed retrospectively.

Opioid-based and opioid-free anesthesia techniques are routinely employed in pediatric ENT procedures in our institution. This study aims to retrospectively evaluate the incidence of emergence agitation and delirium associated with these different anesthesia approaches.

For patients in both groups, the following data will be extracted from medical records: age, sex, weight, diagnosis, comorbidities, presence of allergies, type and duration of surgery, anesthesia technique (opioid-based or opioid-free), frequency and duration of hypotension based on age-specific mean arterial pressure percentiles, total amount of opioids used or total lidocaine dose, BIS suppression time, average BIS value, requirement for additional analgesics during recovery, time from discontinuation of inhalational agents to extubation, and length of stay in the recovery room.

In the postoperative period, all patients are routinely assessed in the recovery unit using PAED, PONV, and either FLACC or NRS scores, which will be retrieved from patient records. Late postoperative pain and patient satisfaction will be assessed based on data obtained from routine surgical outpatient follow-ups.

Patients aged 2 to 18 years with an ASA physical status of I-II will be included in the study. Patients with liver failure, renal failure, advanced heart block (second or third degree), history of cerebrovascular events, regular opioid use, will be excluded.

The primary objective of this study is to retrospectively evaluate the incidence of emergence agitation and delirium following routinely applied opioid-based and opioid-free anesthesia techniques in pediatric patients undergoing ENT surgery. The secondary objective is to retrospectively assess late postoperative pain and patient satisfaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The study will include 126 patients

  • Aged 2-18 years
  • ASA I-II
  • Undergoing elective tonsillectomy, adeoidectomy, cochlear implant surgery under general anesthesia.

Exclusion criteria

  • Patients with ASA 3,4, 5, or 6
  • Liver failure
  • Advanced heart block (second and third degree)
  • Acute cerebrovascular events
  • Mental retardation
  • Patients with tracheostomy
  • Those unwilling to participate

Treatment and study plan

Primary outcomes

  1. WATCHA Score

    Time frame: 1 hour

    The primary aim of the study is to measured the effects of opioid-based versus opioid-free anesthesia procedures on agitation and delirium with WATCHA score(The WATCHA scale has 5 levels: 0-asleep, 1-calm, 2-crying but can be controlled, 3-crying that cannot be controlled and 4-agitated and trashing around) in the postoperative recovery period in children undergoing Ear, Nose, and Throat (ENT) surgeries.

  2. Pediatric Agitation and Delirium Scale

    Time frame: 1 hour

    The primary aim is to assess postoperative agitation scores with Pediatric Agitation and Delirium Scale( all items are scored on a 0-4 point scale as occuring not at all, just a little, quite a bit, very much, or extremely) in the postoperative recovery period in children undergoing Ear, Nose, and Throat (ENT) surgeries.

  3. WATCHA score

    Time frame: 15th minutes

    The primary aim of the study is to measured the effects of opioid-based versus opioid-free anesthesia procedures on agitation and delirium with WATCHA score(The WATCHA scale has 5 levels: 0-asleep, 1-calm, 2-crying but can be controlled, 3-crying that cannot be controlled and 4-agitated and trashing around) in the postoperative recovery period in children undergoing Ear, Nose, and Throat (ENT) surgeries.

  4. Pediatric Agitation and Delirium Scale

    Time frame: 15th minutes

    The primary aim is to assess postoperative agitation scores with Pediatric Agitation and Delirium Scale( all items are scored on a 0-4 point scale as occuring not at all, just a little, quite a bit, very much, or extremely) in the postoperative recovery period in children undergoing Ear, Nose, and Throat (ENT) surgeries.

Secondary outcomes

  1. FLACC

    Time frame: 1 hour

    The secondary aim is to assess postoperative pain scores with NRS or FLACC score(0 to 10 point, with zero meaning "no pain" and 10 meaning "the worst pain imaginable") at 1 hour

  2. FLACC

    Time frame: 15th minutes

    The secondary aim is to assess postoperative pain scores with NRS or FLACC score(0 to 10 point, with zero meanin "no pain" and 10 meaning "the worst pain imaginable") at 1 mounth

  3. Postoperative quality of recovery

    Time frame: 1 month

    The secondary aim is to assess postoperative quality of recovery score (QoR-15- 0 to 150 point, with zero meaning "the worst recovery point" and 150 meaning "the best recovery point") at 1 mounth

  4. Quality of Recovery Score

    Time frame: 1ST week

    The secondary aim is to assess postoperative quality of recovery score (QoR-15- 0 to 150 point, with zero meaning "the worst recovery point" and 150 meaning "the best recovery point") at 1st week

  5. NRS

    Time frame: 15th minutes

    The secondary aim is to assess postoperative pain scores with NRS or FLACC score(0 to 10 point, with zero meaning "no pain" and 10 meaning "the worst pain imaginable") at 1 hour

  6. NRS

    Time frame: 1st hour

    The secondary aim is to assess postoperative pain scores with NRS or FLACC score(0 to 10 point, with zero meaning "no pain" and 10 meaning "the worst pain imaginable") at 1 hour

Sponsors and collaborators

Lead sponsor

Istanbul University - Cerrahpasa

Other

Registry information

Official study title

The Association Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and the Quality of Postoperative Recovery in Pediatric Otolaryngology Cases Monitored With Perioperative Bispectral Index

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 25, 2025
Registry last updated
May 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.